Point72 Hong Kong’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,900
Closed -$1.27M 751
2022
Q3
$1.27M Buy
6,900
+4,100
+146% +$817K 0.04% 489
2022
Q2
$471K Sell
2,800
-2,800
-50% -$602K 0.02% 730
2022
Q1
$1.4M Buy
5,600
+1,200
+27% +$301K 0.05% 418
2021
Q4
$1.13M Sell
4,400
-1,900
-30% -$465K 0.04% 523
2021
Q3
$1.53M Sell
6,300
-100
-2% -$24.4K 0.05% 573
2021
Q2
$1.32M Buy
+6,400
New +$1.3M 0.04% 603
2021
Q1
Sell
-14,100
Closed -$2.32M 1971
2020
Q4
$2.32M Buy
+14,100
New +$2.06M 0.1% 235

Other funds holding HCA

Point72 Hong Kong's HCA Position: Q2 2024 in Review

Point72 Hong Kong sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 10,772 shares — an estimated $3.59M sold.

Point72 Hong Kong first reported a position in HCA in Q3 2014 and held it in 19 quarters. The position peaked at $13.2M in Q2 2022. 1,155 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Point72 Hong Kong reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 10,772 HCA Healthcare shares in Q2 2024, an estimated $3.59M.
  • Point72 Hong Kong first reported a position in HCA Healthcare in Q3 2014 and held it in 19 quarters.
  • Point72 Hong Kong's HCA Healthcare position peaked at $13.2M in Q2 2022.
  • 1,155 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.